NCT03277469 2026-04-22
Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer
Brigham and Women's Hospital
Phase NA Active not recruiting
Clinical Trials
13 trialsNCT07061977 2026-04-22
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT03634267 2026-04-15
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT07530458 2026-04-15
Retinoblastoma Consolidation in Egyptians
Assiut University
Not yet recruiting
NCT00802711 2026-04-13
3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer
Cancer Trials Ireland
Phase NA Terminated
NCT01982786 2026-04-13
Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer
Canadian Cancer Trials Group
Phase NA Completed
NCT02346253 2026-04-13
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Stanford University
Phase NA Active not recruiting
NCT02466971 2026-04-13
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT04214067 2026-04-13
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT05570422 2026-04-08
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Kortuc, Inc.
Phase 1 Recruiting
NCT03543189 2026-04-01
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Active not recruiting
NCT02865837 2026-03-27
VESICOL
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT07276360 2026-03-27
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Recruiting